← Back to Search

Continuous Infusion of Bupivacaine for Pain Management

Phase 3
Waitlist Available
Led By Tarik Wasfie, MD
Research Sponsored by Ascension Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 days
Awards & highlights

Study Summary

This trial looked at whether using a continuous infusion of local anesthetic for postoperative pain control following laparotomy is more effective than using a local anesthetic infiltration technique.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self Reported Pain

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Infused analgesicActive Control1 Intervention
Patients will be assigned to receive local anesthetic through continuous infusion by pump.
Group II: Infused salinePlacebo Group1 Intervention
Patients will be assigned to receive saline through continuous infusion by pump.

Find a Location

Who is running the clinical trial?

Ascension HealthLead Sponsor
24 Previous Clinical Trials
2,916 Total Patients Enrolled
Ascension Genesys HospitalLead Sponsor
18 Previous Clinical Trials
2,148 Total Patients Enrolled
Tarik Wasfie, MDPrincipal InvestigatorAscension Health
2 Previous Clinical Trials
261 Total Patients Enrolled

Media Library

Infused analgesic Clinical Trial Eligibility Overview. Trial Name: NCT04173312 — Phase 3
Pain Management Research Study Groups: Infused saline, Infused analgesic
Pain Management Clinical Trial 2023: Infused analgesic Highlights & Side Effects. Trial Name: NCT04173312 — Phase 3
Infused analgesic 2023 Treatment Timeline for Medical Study. Trial Name: NCT04173312 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a risk of serious bodily harm when taking Infused analgesic?

"There is some level of clinical evidence to support the Infused analgesic's efficacy, as well as numerous studies that suggest Infused analgesic is safe. Consequently, we have given it a score of 3."

Answered by AI

Are there any current vacancies for people who'd like to participate in this research?

"The trial, which was first advertised on clinicaltrials.gov on 1/4/2021, is currently seeking eligible patients."

Answered by AI

Are there any other scientific research papers that mention Infused analgesic?

"There are one hundred and twenty-three active clinical trials studying the efficacy of Infused analgesic. Of these trials, twenty are in Phase 3. Most of the trials for Infused analgesic are based in Philadelphia, Pennsylvania, but there are one hundred and sixty-nine locations running studies for this treatment."

Answered by AI

For what kinds of pain is an infused analgesic commonly prescribed?

"Infused analgesic is a medication used to treat permphigus. It is also sometimes used to manage acute nonspecific tenosynovitis, general anesthesia, and lupus erythematosus cell."

Answered by AI

How many candidates does this experiment have so far?

"That is correct, the information on clinicaltrials.gov does show that this trial is open and recruiting patients. According to the site, the trial was posted on January 4th, 2021 and was last updated on February 22nd, 2022. They are currently recruiting for 120 patients from 1 site."

Answered by AI
~29 spots leftby Mar 2025